Next |
home / stock / pbla / pbla message board
Subject | By | Source | When |
---|---|---|---|
$PBLA in the news following $7 price target: | JDCruz | investorshub | 04/28/2023 5:36:13 PM |
$PBLA Price gaining last trade up | TheFinalCD | investorshub | 04/27/2023 6:54:50 PM |
Long and strong lets hope im right | molee | investorshub | 04/27/2023 5:40:48 PM |
Oh , I can relate , as I | molee | investorshub | 04/27/2023 5:19:45 AM |
Can you imagine how the shareholders feel? IMHO | subslover | investorshub | 04/26/2023 7:06:14 PM |
$PBLA just had a 1:40 stock split Jan. | molee | investorshub | 04/26/2023 7:02:14 PM |
Here is the problem and it will be | subslover | investorshub | 04/26/2023 6:51:21 PM |
I believe something is brewing. It's going up | SriMaharaj | investorshub | 04/26/2023 5:59:50 PM |
$PBLA .49 AGAIN | TheFinalCD | investorshub | 04/26/2023 4:13:49 PM |
$PBLA: No PR's, etc., that I can find either. | Invest-in-America | investorshub | 04/26/2023 1:35:20 PM |
.78 https://www.benzinga.com/news/23/04/32005454/hc-wainwright-co-initiates-coverage-on-panbela-ther | TheFinalCD | investorshub | 04/26/2023 1:32:22 PM |
HC Wainwright initiated coverage with buy recommendation $7 | James salmon | investorshub | 04/26/2023 1:30:23 PM |
nope just tech move | TheFinalCD | investorshub | 04/26/2023 1:19:41 PM |
No News? | subslover | investorshub | 04/26/2023 12:53:24 PM |
$PBLA .73 | TheFinalCD | investorshub | 04/26/2023 12:43:32 PM |
Damn | Awl416 | investorshub | 04/26/2023 12:39:17 PM |
short squeeze signal | molee | investorshub | 04/26/2023 11:57:28 AM |
$PBLA .49 | TheFinalCD | investorshub | 04/26/2023 11:27:21 AM |
$PBLA news out | molee | investorshub | 04/26/2023 8:27:20 AM |
$PBLA Looks pretty positive | Backstabbed | investorshub | 04/25/2023 11:29:47 PM |
News, Short Squeeze, Breakout and More Instantly...
Panbela Therapeutics Inc Com Company Name:
PBLA Stock Symbol:
NASDAQ Market:
MINNEAPOLIS, May 15, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today provides a business update and reports financial results for the q...
Bank of Georgia Group Plc (BDGSF) is expected to report for Q1 2024 iCad Inc. (ICAD) is expected to report for Q1 2024 Yasheng Group (HERB) is expected to report for Q1 2024 Bit Digital Inc. (BTBT) is expected to report $0.01 for Q1 2024 Estrella Immunopharma Inc. (ESLA) is expect...
MINNEAPOLIS, May 06, 2024 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (OTCQB: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, today announced an Issue Notification for the US continuation patent US 11,925,613 B2 ...